Correlation Between Harmony Biosciences and Janux Therapeutics
Can any of the company-specific risk be diversified away by investing in both Harmony Biosciences and Janux Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Harmony Biosciences and Janux Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Harmony Biosciences Holdings and Janux Therapeutics, you can compare the effects of market volatilities on Harmony Biosciences and Janux Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Harmony Biosciences with a short position of Janux Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Harmony Biosciences and Janux Therapeutics.
Diversification Opportunities for Harmony Biosciences and Janux Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Harmony and Janux is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Harmony Biosciences Holdings and Janux Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janux Therapeutics and Harmony Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Harmony Biosciences Holdings are associated (or correlated) with Janux Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janux Therapeutics has no effect on the direction of Harmony Biosciences i.e., Harmony Biosciences and Janux Therapeutics go up and down completely randomly.
Pair Corralation between Harmony Biosciences and Janux Therapeutics
Given the investment horizon of 90 days Harmony Biosciences Holdings is expected to generate 0.73 times more return on investment than Janux Therapeutics. However, Harmony Biosciences Holdings is 1.37 times less risky than Janux Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Janux Therapeutics is currently generating about -0.21 per unit of risk. If you would invest 3,406 in Harmony Biosciences Holdings on December 29, 2024 and sell it today you would lose (71.00) from holding Harmony Biosciences Holdings or give up 2.08% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Harmony Biosciences Holdings vs. Janux Therapeutics
Performance |
Timeline |
Harmony Biosciences |
Janux Therapeutics |
Harmony Biosciences and Janux Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Harmony Biosciences and Janux Therapeutics
The main advantage of trading using opposite Harmony Biosciences and Janux Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Harmony Biosciences position performs unexpectedly, Janux Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janux Therapeutics will offset losses from the drop in Janux Therapeutics' long position.Harmony Biosciences vs. Keros Therapeutics | Harmony Biosciences vs. Janux Therapeutics | Harmony Biosciences vs. Fennec Pharmaceuticals | Harmony Biosciences vs. Edgewise Therapeutics |
Janux Therapeutics vs. Mineralys Therapeutics, Common | Janux Therapeutics vs. Anebulo Pharmaceuticals | Janux Therapeutics vs. Rezolute | Janux Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |